Oct 8 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:
ARS PHARMACEUTICALS RECEIVES FAVORABLE DECISION FROM EUROPEAN PATENT OFFICE ON PATENT RELATED TO NEFFY® (EPINEPHRINE NASAL SPRAY)
ARS PHARMACEUTICALS : GLOBAL INTELLECTUAL PROPERTY PORTFOLIO RELATED TO NEFFY PROVIDES COVERAGE UNTIL AT LEAST 2039